Fast And Furious: Lessons From China FDA's Innovation Push
This article was originally published in SRA
Executive Summary
Last July, when the China Food and Drug Administration's commissioner Bi Jingquan gave a speech during a ceremony at Peking University's Pharmaceutical Engineering Management class, no one realized that it marked the start of a new era of drug regulation in the country.
You may also be interested in...
China Regulatory Shakeup: Top Regulator Out, Commissioner Reprimanded Amid Vaccine Scandal
Amid aftermath of latest vaccine scandal, top officials including China’s drug reform flagbearer are forced to resign, sending shock waves across the industry.
2016 Review: Rapid Change Defines China Regulatory Environment
If you missed some of the many significant events in China’s policy and regulatory landscape in 2016, here is your opportunity to catch up on month-by-month developments.
China Regulatory Watch: New Fast-Track Designations, CTAs
China Regulatory Watch is our new snapshot of product-specific regulatory developments at the China FDA.